×
IVF Information

News Center

Current position: Blessed Future > IVF Information >

How to Read CDC and SART Data Before Choosing an IVF Clinic in the US: Comparing Success Rates and Cost per Live Birth Without Falling for Marketing Numbers

Release time: 2026-11-20 Blessed Future

Treat CDC and SART numbers as inputs to a cost calculation rather than a scoreboard. Divide each clinic's total expected spend, including medications, PGT-A testing, and frozen embryo transfers, by its verified live birth rate. The result, cost per live birth, routinely reverses rankings built on per-cycle prices, because a clinic charging 30 percent less per cycle can still cost more per baby when its success rate runs ten points lower.

Why is the per-cycle quote a marketing unit instead of a decision unit?

The number a clinic puts on its website answers a question almost nobody actually faces. Very few patients complete IVF in one fresh cycle with no additional procedures, yet that is exactly the scenario a standalone cycle price describes. When you pay attention to what happens after the retrieval, the arithmetic changes shape.

Start by listing the components that a typical IVF attempt actually contains. There is the base cycle itself: monitoring appointments, the retrieval, anesthesia, and the embryology work. Medications for ovarian stimulation usually run on a separate invoice from the pharmacy, and the range is wide depending on protocol and dosage. Preimplantation genetic testing for aneuploidy, if you use it, is billed per embryo biopsied plus a platform fee. Then comes the frozen embryo transfer, which many clinics bill as a distinct procedure with its own monitoring, thaw, and transfer fees. Some clinics bundle some of these items; others quote the base cycle alone and let the rest surface later.

This structure is where marketing lives. A headline price of, say, twelve to fifteen thousand dollars for a cycle is a real number, but it describes one slice of one attempt. The Centers for Disease Control and Prevention's own consumer guidance on fertility clinics and treatment costs notes that total treatment cost depends on how many cycles and procedures a patient needs, which is precisely the variable a single-cycle quote hides. Industry-wide, a fully loaded attempt with medications, genetic testing, and a frozen transfer commonly lands somewhere between roughly twenty and thirty-five thousand dollars, though you should verify current figures against each clinic's published fee schedule, because pricing models differ and change.

To turn this into a decision tool, build the full equation for each clinic you are considering:

Cost per live birth = (base cycle + medications + PGT-A + frozen embryo transfer fees) × expected number of attempts ÷ cumulative probability of a live birth across those attempts.

Every variable in that equation is checkable. The fee schedule sits on the clinic's website or in its financial counselor's packet. The success rate comes from the CDC's ART Success Rates database or the SART clinic outcomes tool, both of which report live birth rates per intended egg retrieval, broken down by age group. The expected number of attempts is your own planning assumption, which the last section of this article helps you set.

One practical drill: ask each clinic's financial office three questions in writing. Does the quoted package include medications? Does it include PGT-A biopsy fees, and at what per-embryo rate? Does it include one frozen embryo transfer, and if so, how many? Clinics vary enormously here. Some high-volume operations, such as CNY Fertility in New York, have built their model around published multi-service packages that fold several of these line items together, which is why their sticker prices look dramatically lower than coastal competitors; whether the package matches your protocol is the question to resolve before comparing it to anything else. Other clinics quote the retrieval only. A package that includes a frozen transfer and a package that does not can differ by five figures once you simulate a realistic course of treatment, so the sticker comparison is meaningless until the contents are normalized.

Watch for a specific pattern on clinic websites: success rate pages that cite live birth rates per transfer while pricing pages quote per retrieval. Those denominators are not interchangeable. Per-transfer rates run higher because the weakest cycles, the ones that never produced a usable embryo, have already dropped out of the denominator. If a clinic markets a per-transfer rate next to a per-retrieval price, it is pairing its most flattering outcome metric with its least complete cost metric. The CDC database lets you check both denominators for the same clinic, which makes this mismatch easy to catch.

How much does a 5-point success rate gap move cost per live birth?

Success rates behave like a lever on cost because they sit in the denominator of the equation. Small percentage differences compound into large dollar differences. A short sensitivity analysis makes the effect concrete.

Set up two hypothetical clinics with realistic figures. Clinic A reports a 55 percent live birth rate per transfer for your age group in the most recent CDC or SART data. Its fully loaded attempt costs $27,500 once medications, PGT-A, and a frozen transfer are included. Clinic B reports 40 percent for the same age group. Its website advertises a base cycle priced 30 percent below Clinic A's, which sounds decisive.

Now run the numbers with the structure marketing tends to obscure. Suppose the 30 percent discount applies only to the base cycle, while medications, testing, and the frozen transfer are billed at market rates by both clinics. If the base cycle is $15,000 and the add-ons total $12,500, Clinic A's full attempt costs $27,500. Clinic B's discounted base is $10,500, so its full attempt is $23,000. The expected cost per live birth, assuming you keep trying until success, is the full attempt cost divided by the per-attempt probability:

Metric Clinic A Clinic B
Live birth rate per transfer 55% 40%
Advertised base cycle price $15,000 $10,500 (30% off)
Full attempt cost with add-ons $27,500 $23,000
Expected cost per live birth $27,500 ÷ 0.55 = $50,000 $23,000 ÷ 0.40 = $57,500

Clinic B is cheaper per attempt and more expensive per baby. The 30 percent discount on the visible line item was worth $4,500 per attempt; the 15-point success gap cost $7,500 in expected value per live birth. These are illustrative figures built on a worked example, not a claim about any specific clinic, but the direction of the effect is structural and shows up whenever the success gap outweighs the price gap.

You can compute the exact tipping point for any pair of clinics. The breakeven success rate for the cheaper clinic is:

Breakeven rate for Clinic B = Clinic A's rate × (Clinic B's full attempt cost ÷ Clinic A's full attempt cost).

In the example: 0.55 × ($23,000 ÷ $27,500) = 0.55 × 0.836 = about 46 percent. Clinic B needs a 46 percent live birth rate merely to match Clinic A's cost per live birth. At 40 percent it falls short, and every point below 46 widens the shortfall. Run this calculation before you let a discount influence you, because the breakeven rate tells you how good the cheaper clinic would need to be for the savings to survive contact with outcomes data. If the breakeven rate sits above what the CDC or SART data actually shows for that clinic, the discount is decorative.

Two boundary conditions deserve attention. First, this arithmetic assumes comparable patient populations. A clinic whose numbers reflect younger patients or lower complexity cases will show higher rates that say little about your own prospects; the CDC database's age-specific breakdowns are the main defense against this, and SART's clinic profiles add cycle volume context. Second, the calculation assumes you would keep attempting until a live birth or until you stop for personal reasons. If your plan caps attempts at two, use the two-attempt cumulative probability for both clinics instead of the single-attempt rate, and the ranking can shift again. The formula is flexible; the discipline of using the same denominator on both sides is what matters.

How stale are the CDC and SART numbers you are reading?

Every success rate you compare is a historical record, and the gap between the data year and your treatment year is routinely two years or more. The CDC's annual ART report and its public fertility clinic success rates tool publish clinic-level outcomes with a reporting lag of roughly two years, because clinics submit cycle data, the data gets validated, and the aggregated report follows. A rate you read in 2026 typically describes cycles from 2023 or earlier. During that gap, several things that materially affect outcomes can happen without any trace in the published figure.

Laboratory relocation is the clearest example. Embryology outcomes are sensitive to lab conditions, equipment, and staff continuity, and clinics do move or rebuild labs. A clinic whose published 55 percent was earned in one facility may be running a different lab by the time you cycle. Physician departures work similarly; a named reproductive endocrinologist's published results may partly reflect a team that no longer exists in the same form. Patient mix also drifts. A clinic that begins treating a larger share of patients with prior failed cycles, or that changes its PGT-A policy, can shift its outcome profile in ways the old report cannot show.

Three verification habits close most of this gap. First, on the SART clinic outcomes tool at sart.org, check the reporting year attached to each outcome table and look for the verification status; SART requires member clinics to submit their cycle data and validates it before publication, and the tool indicates whether a clinic's data is SART-verified. On the CDC's fertility clinic success rates site, the same discipline applies: read the data year printed with the rates before comparing anything. Second, cross-check the clinic's own news page, and search the practice name together with terms like "new laboratory" or "new location" for the period after the data year. A lab move is not automatically bad news, but it is information you deserve before committing five figures. Third, ask the clinic directly, in writing, two questions: what year does your published success data cover, and has your embryology lab or medical director changed since then? A clinic that answers clearly is telling you something useful about how it operates; evasion is itself a data point.

Sample size is the other quiet distortion. A clinic performing a small number of cycles in your age group can post a spectacular rate on a handful of attempts, and the rate will swing wildly year to year. Both the CDC and SART presentations include cycle counts alongside rates for exactly this reason. As a working rule, give more weight to rates built on larger cycle volumes in your specific age bracket, and treat a high rate on a small denominator as unproven. The CDC's own materials caution that clinic differences often reflect patient characteristics, which is why the database also publishes national averages for each age group as a reference line.

What does the Nth failed attempt actually cost?

Budget planning built on a single-cycle price systematically underfunds treatment, because the relevant quantity is the marginal cost of each additional try. The cumulative live birth math makes this visible.

If a clinic's per-attempt live birth probability is p, the probability of a live birth within n attempts is 1 − (1 − p)n. Take p = 45 percent, a plausible mid-range figure for many age groups, and a full attempt cost of $27,500 from the earlier example. One attempt gives a 45 percent cumulative chance. Two attempts give 1 − 0.55² = about 70 percent. Three attempts reach about 83 percent, and four attempts about 91 percent. Notice how each additional attempt buys less: the first attempt contributes 45 points of probability, the second 25 points, the third 13 points, the fourth about 7 points.

Translate those probability gains into money and the marginal cost per additional live birth climbs steeply:

  • Attempt 1: $27,500 ÷ 0.45 ≈ $61,000 per live birth attributable to that attempt
  • Attempt 2: $27,500 ÷ (0.45 × 0.55) ≈ $111,000
  • Attempt 3: $27,500 ÷ (0.45 × 0.55²) ≈ $202,000
  • Attempt 4: $27,500 ÷ (0.45 × 0.55³) ≈ $367,000

These figures describe the cost of the live births delivered by each specific attempt, which is the right lens for deciding whether to continue. A fourth attempt is not priced at $27,500 in decision terms; it is priced at roughly $367,000 per additional baby it delivers, because most of its probability mass overlaps with outcomes the first three attempts already covered. This is why financial counselors and reproductive endocrinologists generally frame budget conversations around a planned series of cycles. The American Society for Reproductive Medicine's patient guidance on financing treatment similarly directs patients to think in terms of total treatment cost across multiple cycles, and it points to multi-cycle programs and shared-risk style refund plans as structures built around exactly this reality. Whether any such plan is worth its premium depends on the fine print, including what counts as a qualifying cycle and what is refunded, so read the contract terms before assigning it any value.

The planning rule that follows: set your budget as expected attempts × full attempt cost, with a buffer, rather than as one cycle's price. If you plan up to three attempts at a 45 percent clinic, budget roughly $82,500 plus a margin, and know in advance what stopping rule you will use, whether that is a cumulative probability target, a financial ceiling, or a response-to-stimulation threshold your physician defines. Deciding the stopping rule before the first retrieval removes the most expensive decision in fertility care, which is the one made under emotional pressure after a negative pregnancy test, when the marginal cost math above is least likely to feel persuasive.

One reframe helps here. A failed attempt is commonly mourned as money burned. In the cumulative model it functions more like an installment payment on a probability you are buying in stages. That does not make continued attempts automatically rational; the rising marginal cost is real, and for some profiles the expected value of attempt four is genuinely poor. It does mean the honest comparison is between the marginal cost of the next attempt and your remaining budget and goals, with the cumulative curve from CDC or SART data for your age group as the reference, instead of a gut reading of the last cycle as a verdict on the clinic.

Which kinds of clinics does this arithmetic favor?

The cost-per-live-birth framework does not produce a single winner, but it does clarify what to look for by clinic type. High-volume, published-package operations such as CNY Fertility tend to compress the cost numerator, which is powerful when their verified rates for your age group are competitive; the diligence task is confirming exactly what the package covers and checking their SART-verified outcomes for your bracket. Multi-site practices with broad geographic footprints, such as Shady Grove Fertility or HRC Fertility, make it easier to find a location where monitoring and transfers fit your life, which matters because travel friction quietly causes protocol deviations. Boutique practices such as Spring Fertility in the San Francisco Bay Area or San Diego Fertility Center compete on protocol personalization and lab attention, a value proposition that only shows up in the denominator, so their case rests on whether their verified rates for your age group justify their pricing. All published rates and prices should be confirmed against each clinic's official materials and the current CDC and SART databases, since both change annually.

FAQ

Is a clinic advertising a 70 percent success rate telling the truth?

The first sentence of the answer: the rate may be technically accurate and still be misleading, because the denominator and the year do the work. Check three things before believing any headline figure. Whether the rate is per transfer or per intended retrieval, since per-transfer rates run higher by construction. Which age group it describes, since rates for patients under 35 can exceed double the rates for patients in their early forties. And which year the data covers, since clinics sometimes cite their best recent year. The CDC's ART Success Rates tool and the SART outcomes tool both report age-specific, denominator-specific rates with the data year attached, so any clinic claim can be checked against those sources in a few minutes.

How far behind is CDC data when I read it today?

The first sentence: expect roughly a two-year lag between the cycles described and the report you are reading. The CDC validates submitted cycle data before publishing clinic-level results, so the most recent report typically covers cycles from two or more years earlier. That lag is why the verification habit matters: read the data year on the CDC or SART page, then check the clinic's announcements for lab relocations, physician changes, or protocol shifts since that year, and ask the clinic in writing whether anything material has changed.

Should I just pick the cheapest IVF clinic in the US?

The first sentence: pick the lowest expected cost per live birth among clinics whose verified rates apply to your age group, and the cheapest sticker price often loses that comparison. Run the breakeven calculation: multiply the stronger clinic's live birth rate by the ratio of the two clinics' full attempt costs, including medications, PGT-A, and frozen transfer fees. If the cheaper clinic's verified rate falls below that breakeven figure, the discount costs you money in expectation. Price only wins when the success rates are close or when the discount applies to the complete attempt rather than the base cycle.

How many IVF attempts should I budget for?

The first sentence: budget for the number of attempts whose cumulative probability you find acceptable, priced at the full attempt cost, not the advertised cycle price. Use the cumulative formula 1 − (1 − p)n with your age group's rate from CDC or SART data. At a 45 percent per-attempt rate, three attempts buy roughly an 83 percent cumulative chance, so a three-attempt plan at $27,500 per attempt means budgeting around $82,500 with a buffer. Decide your stopping rule before starting, because the marginal cost per additional live birth rises sharply with each attempt, and that decision is hardest to make well after a failed cycle.

Do multi-cycle discount packages actually save money?

The first sentence: they can, but only if the fine print matches your realistic treatment path. Multi-cycle and refund-style programs price in the possibility of failure, so their premium is actuarially justified only when you would plausibly need the extra cycles anyway. Before signing, verify what counts as a qualifying cycle, whether frozen transfers and PGT-A are included, what happens if you succeed on the first attempt, and how the program's terms interact with your state's insurance coverage if any applies. Then compare the program's effective cost per live birth against the pay-as-you-go calculation for the same clinic; the comparison, rather than the discount percentage, is what determines value.

Contact Us